Tue 9/2/2014 05:06 ET
DJIA17098.4518.810.11%SOLAR43.390.340.79%GOLD1286.400.180.18%Shanghai2266.0531.041.37%
S&P 5002003.376.610.33%BANKS23.360.110.47%OIL95.96130.511.36%Nikkei15668.60194.291.24%
NASDAQ4580.2722.900.50%SEMI51.680.400.78%US/EU0.760.020.02%Futures2005.804.400.22%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Applied Science & Technology Inc - ASTX   

ANNOUNCEMENT: Welcome back. TheLion.com has moved to a new service provider. Please report any issues to webmaster@thelion-inc.com. Thanks!

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add ASTX
  
From: all2tropical (Rep: 206)Date: 02/09/2012 13:47
Forum: Applied Science & Technology Inc - Msg #7Thread #673358445 (Rec: 0)
another one bites the dust...(H) DJ FDA's Oncologic Drugs Advisory Committee (ODAC) Votes To Not Support Benefit/Risk Profile Of DACOGEN(R) (decitabine) In Acute Myeloid Leukemia >ASTX
(MORE TO FOLLOW) Dow Jones Newswires (212-416-2400) February 09, 2012 13:46 ET (18:46 GMT) Copyright (c) 2012 Dow Jones & Company, Inc.- - 01 46 PM EST 02-09-12



Share This Post:


http://www.kirkreport.com/pictures/sumo_market.gif



***Disclaimer & Disclosure***: I make no guarantee as to the accuracy or validity of information in this message... 

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser all2tropical: Reward | Watch | IgnoreASTX: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add ASTX
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.